{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T20:14:23Z","timestamp":1779912863427,"version":"3.53.1"},"reference-count":39,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T00:00:00Z","timestamp":1727136000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"abstract":"<jats:p><jats:italic>Streptococcus pneumoniae<\/jats:italic> is an important cause of community-acquired pneumonia (CAP) in Japan. Here, we report the serotype distribution and antimicrobial susceptibility of cultured pneumococcal isolates from Japanese adults aged \u226518\u2009years with CAP. This was a prospective, population-based, active surveillance study conducted in Goto City, Japan from December 2015 to November 2020. Pneumococcal isolates from sterile sites (blood and pleural fluid) and non-sterile sites (sputum and bronchoalveolar lavage) were cultured as part of the standard of care. <jats:italic>S. pneumoniae<\/jats:italic> were serotyped using the Quellung reaction. Antimicrobial susceptibility was tested using microdilution and interpreted according to the Clinical and Laboratory Standards Institute criteria. Isolates resistant to erythromycin were phenotyped using the triple-risk test and genotyped by polymerase chain reaction. A total of 156 pneumococcal isolates were collected (138 from sputum, 15 from blood, and 3 from bronchoalveolar lavage) from 1992 patients. Of these, 142 were non-duplicate isolates from unique patients and were included in the analyses. Serotypes contained within the 13-valent pneumococcal conjugate vaccine (PCV13) (including 6C), PCV15 (including 6C), and PCV20 (including 6C and 15C) were detected in 39 (27%), 45 (32%), and 80 (56%) of 142 isolates, respectively. The most common serotypes were 35B (12%), 11A (11%), and 3 (11%). Multidrug resistance (MDR) was detected in 96\/142 (68%) isolates. Of the 96 MDR isolates, 31, 32, and 59% were PCV13, PCV15, and PCV20 serotypes, respectively; the most common MDR serotypes were 35B (16%), 6C, 10A, and 15A (9% each), and 3 and 11A (8% each). A total of 119 isolates were resistant to macrolides; 41 (35%) had an M phenotype, 53 (45%) had an iMcLS phenotype, and 25 (21%) had a cMLS phenotype. In conclusion, pneumococcal serotypes 35B, 11A and 3 were most frequently associated with pneumonia and antimicrobial resistance was common among pneumococcal isolates from adults with CAP in Goto City, Japan. Implementing higher-valency PCVs May help reduce vaccine-type CAP among Japanese adults.<\/jats:p>","DOI":"10.3389\/fmicb.2024.1458307","type":"journal-article","created":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T13:34:50Z","timestamp":1727184890000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Serotype distribution and antimicrobial susceptibility of Streptococcus pneumoniae isolates cultured from Japanese adult patients with community-acquired pneumonia in Goto City, Japan"],"prefix":"10.3389","volume":"15","author":[{"given":"Taiga","family":"Miyazaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"van der Linden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuji","family":"Hirano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeru","family":"Kohno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa N.","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pingping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raul E.","family":"Isturiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon L.","family":"Gray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsay R.","family":"Grant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael W.","family":"Pride","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradford D.","family":"Gessner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Jodar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriano G.","family":"Arguedas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,9,24]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1080\/14760584.2020.1750378","article-title":"Upper respiratory tract colonization with Streptococcus pneumoniae in adults","volume":"19","author":"Arguedas","year":"2020","journal-title":"Expert Rev. Vaccines"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"e5","DOI":"10.21037\/arh.2018.05.01","article-title":"Treatment guidelines for community-acquired pneumonia","volume":"2","author":"Bender","year":"2018","journal-title":"Ann. Res. Hospitals"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.ijantimicag.2011.01.019","article-title":"Mef(a) is the predominant macrolide resistance determinant in Streptococcus pneumoniae and Streptococcus pyogenes in Germany","volume":"37","author":"Bley","year":"2011","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1128\/MMBR.65.2.232-260.2001","article-title":"Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance","volume":"65","author":"Chopra","year":"2001","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"ref5","year":"2024"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1086\/597044","article-title":"Introduction and proliferation of multidrug-resistant Streptococcus pneumoniae serotype 19A clones that cause acute otitis media in an unvaccinated population","volume":"199","author":"Dagan","year":"2009","journal-title":"J. Infect. Dis."},{"key":"ref7","doi-asserted-by":"crossref","first-page":"4184","DOI":"10.1128\/AAC.00598-07","article-title":"The macrolide resistance genes erm(B) and mef(E) are carried by Tn2010 in dual-gene Streptococcus pneumoniae isolates belonging to clonal complex CC271","volume":"51","author":"Del Grosso","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1128\/AAC.45.6.1721-1729.2001","article-title":"Antimicrobial resistance among clinical isolates Ofstreptococcus pneumoniaein the United States during 1999\u20132000, including a comparison of resistance rates since 1994\u20131995","volume":"45","author":"Doern","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref9","year":"2023"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1186\/1471-2334-14-534","article-title":"Validation of sputum gram stain for treatment of community-acquired pneumonia and healthcare-associated pneumonia: a prospective observational study","volume":"14","author":"Fukuyama","year":"2014","journal-title":"BMC Infect. Dis."},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1128\/AAC.43.8.1935","article-title":"Phenotypes and genotypes of erythromycin-resistant Streptococcus pyogenes strains in Italy and heterogeneity of inducibly resistant strains","volume":"43","author":"Giovanetti","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1093\/cid\/ciaa595","article-title":"One-year quality of life post-pneumonia diagnosis in Japanese adults","volume":"73","author":"Glick","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"ref13","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.vaccine.2013.06.040","article-title":"Using the impact of pneumococcal vaccines on nasopharyngeal carriage to aid licensing and vaccine implementation; a PneumoCarr meeting report march 27-28, 2012, Geneva","volume":"32","author":"Goldblatt","year":"2013","journal-title":"Vaccine"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"7057","DOI":"10.1016\/j.vaccine.2022.10.010","article-title":"Cost-effectiveness analyses of 15- and 20-valent pneumococcal conjugate vaccines for Japanese elderly","volume":"40","author":"Hoshi","year":"2022","journal-title":"Vaccine"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"e0287297","DOI":"10.1371\/journal.pone.0287297","article-title":"Investigation of oral macrolide prescriptions in Japan using a retrospective claims database, 2013\u20132018","volume":"18","author":"Ide","year":"2023","journal-title":"PLoS One"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"2010956","DOI":"10.1080\/20016689.2021.2010956","article-title":"Burden of illness associated with pneumococcal infections in Japan - a targeted literature review","volume":"10","author":"Igarashi","year":"2022","journal-title":"J Mark Access Health Policy"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"675225","DOI":"10.3389\/fmed.2021.675225","article-title":"Bacterial Spectrum of spontaneously ruptured otitis media in a 7-year, longitudinal, multicenter, epidemiological cross-sectional study in Germany","volume":"8","author":"Im\u00f6hl","year":"2021","journal-title":"Front Med"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1128\/JCM.01430-06","article-title":"Genotypes and related factors reflecting macrolide resistance in pneumococcal pneumonia infections in Japan","volume":"45","author":"Isozumi","year":"2007","journal-title":"J. Clin. Microbiol."},{"key":"ref1002","year":"2023"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1086\/648678","article-title":"Etiology of community-acquired pneumonia: increased microbiological yield with new diagnostic methods","volume":"50","author":"Johansson","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/j.jiph.2020.04.012","article-title":"High prevalence of antimicrobial resistance in non-vaccine serotypes of non-invasive\/colonization isolates of Streptococcus pneumoniae: a cross-sectional study eight years after the licensure of conjugate vaccine in Japan","volume":"13","author":"Kawaguchiya","year":"2020","journal-title":"J. Infect. Public Health"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr7203a1","article-title":"Pneumococcal vaccine for adults aged \u226519 years: recommendations of the advisory committee on immunization practices, United States, 2023","volume":"72","author":"Kobayashi","year":"2023","journal-title":"MMWR Morb. Mortal Wkly. Rep."},{"key":"ref22","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1089\/107662900419483","article-title":"Antibiotic susceptibility patterns and serotypes of antibiotic resistant and\/or invasive Streptococcus pneumoniae strains circulating in Italy","volume":"6","author":"Marchese","year":"2000","journal-title":"Microb. Drug Resist."},{"key":"ref23","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1164\/rccm.201908-1581ST","article-title":"Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America","volume":"200","author":"Metlay","year":"2019","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref24","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.jiac.2015.12.019","article-title":"JAID\/JSC guidelines for the treatment of respiratory infectious diseases: the Japanese Association for Infectious Diseases\/Japanese Society of Chemotherapy\u2014the JAID\/JSC guide to clinical Management of Infectious Disease\/guideline-preparing committee respiratory infectious disease WG","volume":"22","author":"Mikasa","year":"2016","journal-title":"J. Infect. Chemother."},{"key":"ref25","doi-asserted-by":"publisher","first-page":"100007","DOI":"10.1016\/j.chpulm.2023.100007","article-title":"Community-acquired pneumonia incidence in adults aged 18 years and older in Goto City, Japan: a prospective population-based study","volume":"1","author":"Miyazaki","year":"2023","journal-title":"CHEST Pulmonary"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"2236","DOI":"10.1128\/AAC.47.7.2236-2241.2003","article-title":"Phenotypic and molecular characterization of tetracycline- and erythromycin-resistant strains of Streptococcus pneumoniae","volume":"47","author":"Montanari","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref27","doi-asserted-by":"publisher","first-page":"e0122247","DOI":"10.1371\/journal.pone.0122247","article-title":"The burden and etiology of community-onset pneumonia in the aging Japanese population: a multicenter prospective study","volume":"10","author":"Morimoto","year":"2015","journal-title":"PLoS One"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s41479-022-00097-y","article-title":"The remarkable history of pneumococcal vaccination: an ongoing challenge","volume":"14","author":"Musher","year":"2022","journal-title":"Pneumonia"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1016\/j.vaccine.2019.12.022","article-title":"Nationwide surveillance of paediatric invasive and non-invasive pneumococcal disease in Japan after the introduction of the 13-valent conjugated vaccine, 2015-2017","volume":"38","author":"Nakano","year":"2020","journal-title":"Vaccine"},{"key":"ref30","author":"Ono","year":"2023"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1128\/AAC.47.6.1832-1835.2003","article-title":"Antimicrobial resistance of invasive pneumococci in Finland in 1999\u20132000","volume":"47","author":"Pihlajam\u00e4ki","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref32","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1093\/jac\/47.6.863","article-title":"Distribution of resistance genes tet(M), aph3'-III, catpC194 and the integrase gene of Tn1545 in clinical Streptococcus pneumoniae harbouring erm(B) and mef(a) genes in Spain","volume":"47","author":"Seral","year":"2001","journal-title":"J. Antimicrob. Chemother."},{"key":"ref33","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1136\/thoraxjnl-2019-213929","article-title":"British Thoracic Society guideline for the use of long-term macrolides in adults with respiratory disease","volume":"75","author":"Smith","year":"2020","journal-title":"Thorax"},{"key":"ref34","year":"2024"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.3201\/eid2111.142029","article-title":"Serotype changes and drug resistance in invasive pneumococcal diseases in adults after vaccinations in children, Japan, 2010\u20132013","volume":"21","author":"Ubukata","year":"2015","journal-title":"Emerg. Infect. Dis."},{"key":"ref36","doi-asserted-by":"publisher","first-page":"e8286","DOI":"10.1371\/journal.pone.0008286","article-title":"Molecular characterization of pneumococcal isolates from pets and laboratory animals","volume":"4","author":"Van Der Linden","year":"2009","journal-title":"PLoS One"},{"key":"ref37","year":"2019"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.ijid.2020.10.017","article-title":"Serotype distribution and antimicrobial susceptibility of Streptococcus pneumoniae associated with invasive pneumococcal disease among adults in Japan","volume":"102","author":"Yanagihara","year":"2021","journal-title":"Int. J. Infect. Dis."}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2024.1458307\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T13:34:53Z","timestamp":1727184893000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2024.1458307\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,24]]},"references-count":39,"alternative-id":["10.3389\/fmicb.2024.1458307"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2024.1458307","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,24]]},"article-number":"1458307"}}